SQA

AUGUST 8, 2023

Possibility of carrying out clinical analysis evaluation in pharmacies, in the context of health care and pharmaceutical services, on a screening basis and in isolated offices. Normative forecast and definition of technical and infrastructure parameters for the operation of biological materials distribution centers. Floor 9, No.

FDA 40

FDA Compliance COVID-19 World Health 40

SQA

AUGUST 8, 2023

Possibility of carrying out clinical analysis evaluation in pharmacies, in the context of health care and pharmaceutical services, on a screening basis and in isolated offices. Normative forecast and definition of technical and infrastructure parameters for the operation of biological materials distribution centers. Floor 9, No.

FDA 40

FDA Compliance COVID-19 World Health 40

SQA

DECEMBER 16, 2022

China’s Center for Medical Device Evaluation (CMDE) Update Compliance Guidelines and Recommended Paths for Clinical Evaluation Paths for Certain Medical Devices, 25 July 2022. 29 of 2022 , Technical Guidelines for Compliance with the Essential Principles of Medical Device Safety and Performance. CMDE Announcement No.

FDA 40

FDA Compliance COVID-19 Licensing 40

SQA

AUGUST 1, 2024

Companies participating in the program will receive annual audits to monitor the risk and verify the maintenance of compliance with GMP, contributing to the control of the health risk of the products. Non-Compliance Rating for Upmaid Technologies Inc., This indicated a lack of proper implementation of the necessary CAPAs.

FDA 40

FDA Licensing Compliance World Health 40

SQA

OCTOBER 18, 2023

The following is a summary of a Canadian case report that was evaluated by Health Canada, describing an error associated with confusion about the labelled strength of a mineral supplement: In this case, the prescription was dispensed by the pharmacy using a product labelled as Calcium Carbonate 500 mg. Definitions.

FDA 40

FDA Compliance Licensing World Health 40

SQA

OCTOBER 18, 2023

The following is a summary of a Canadian case report that was evaluated by Health Canada, describing an error associated with confusion about the labelled strength of a mineral supplement: In this case, the prescription was dispensed by the pharmacy using a product labelled as “Calcium Carbonate 500 mg”. Definitions.

FDA 40

FDA Compliance Licensing World Health 40

SQA

FEBRUARY 26, 2024

After receiving complaints, ANVSA performed joint inspections with local health surveillance agencies. The reported irregularities and the manufacturing conditions of the products, that is, compliance with Good Manufacturing Practices, were verified on the spot.

FDA 52

FDA Compliance COVID-19 Public Health 52

SQA

FEBRUARY 26, 2024

After receiving complaints, ANVSA performed joint inspections with local health surveillance agencies.The reported irregularities and the manufacturing conditions of the products, that is, compliance with Good Manufacturing Practices,were verifiedon the spot.

FDA 40

FDA Compliance COVID-19 Public Health 40

SQA

JUNE 3, 2024

A health professional, in the context of a directed donation, did not create a document stating that, in their medical opinion, the use of sperm or ova would not pose a serious risk to human health and safety. Now the Ministry of Health has published revised regulations in accordance with Annex M of the Drugs and Cosmetics Rules.

FDA 40

FDA COVID-19 Licensing Nurses 40

SQA

APRIL 30, 2021

The European Medical Device Coordination Group (MDCG) has issued a new document covering key questions and considerations regarding custom-made medical devices in the context of Medical Devices Regulation (MDR) compliance. These missions will allow the Commission to identify, and, if necessary, correct any non-compliance or weaknesses.

COVID-19 Vaccine 52

COVID-19 Vaccine COVID-19 Compliance Governance 52

SQA

OCTOBER 18, 2022

Health Canada also received confirmation from the purchaser of the counterfeit products that they had purchased the kits for personal use. The entire shipment, which contained 435 boxes of the 25-pack, was sent to Health Canada for compliance follow-up. and one distributor, Healthful Plus. Health Advance Inc.

US Department of Health and Human Services 40

US Department of Health and Human Services FDA COVID-19 Compliance 40